Summary
The pokeweed-mitogen-induced transformation of B-lymphocytes into immunoglobulin-secreting cells was studied in vitro in 25 patients with multiple myeloma using a reverse hemolytic plaque assay. Fifteen patients showed a good response in generating immunoglobulin-secreting cells, whereas 10 patients showed a decreased B cell reactivity which was not due to intermittent melphalan/steroid therapy administered to 15 patients. Experiments with lymphocyte subpopulations demonstrated that the inability of some multiple-myeloma patients to generate immunoglobulin-secreting cells was always based on a defect in the B-cell subset. Co-culture experiments with lymphocytes from normal individuals and patients revealed a cell-mediated suppression in one case, whereas humoral suppressive factors in the patients' serum could not be observed using the reverse hemolytic plaque assay. Patients were classified into three groups: (a) patients with a normal B-cell function, (b) patients with a reversible, tumor-dependent suppression of B-cell reactivity and (c) patients in whom the normal B-cell population was replaced by non-reactive cells.
Zusammenfassung
Die durch Pokeweed Mitogen induzierte Transformation von B Lymphozyten in Immunglobulin-sezernierende Zellen wurde bei 25 Patienten mit multiplem Myelom in einem indirekten Plaque Assay untersucht. Fünfzehn Patienten zeigten ein normales Verhalten bezüglich der Zahl der Immunglobulin-sezernierenden Zellen, während 10 Patienten eine erniedrigte B Zell Reaktivität aufwiesen, die nicht auf eine bei 15 Patienten angewandte Melphalan/Steroid Therapie bezogen werden konnte. Experimente mit Lymphozyten-Subpopulationen zeigten, daß die bei einigen Patienten fehlende Transformationsfähigkeit immer allein auf einem Defekt der B Zell-Population beruhte. In Ko-Kulturexperimenten mit Lymphozyten von Normalpersonen und von Patienten mit multiplem Myelom konnte in einem Fall eine zellvermittelte Suppression festgestellt werden, während humorale supprimierende Faktoren im Serum von Patienten mit der angewandten Technik des indirekten Plaque Assays nicht nachgewiesen werden konnten. Die Patienten ließen sich in 3 Gruppen einteilen: (a) Patienten mit einer normalen B Zellfunktion, (b) Patienten mit einer reversiblen, tumorabhängigen Suppression der B Zellreaktivität und (c) Patienten, bei denen die normale B Zellpopulation durch nicht reaktive Zellen ersetzt war.
Similar content being viewed by others
Abbreviations
- Ig:
-
Immunoglobulin(s)
- RHPA:
-
Reverse hemolytic plaque assay
- ISC:
-
Immunoglobulin-secreting cells
- PWM:
-
Pokeweed mitogen
- FCS:
-
Fetal calf serum
- MM:
-
Multiple Myeloma
References
Adler WH, Takiguchi T, Smith RT (1971) Phytohemagglutinin unresponsiveness in mouse spleens induced by methylcholanthrene sarcomas. Cancer Res 31:864–867
Alexanian R, Migliore PJ (1970) Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy. J Lab Clin Med 75:225–233
Alper CA, Freeman T, Waldenström J (1963) The metabolism of gamma globulins in multiple myeloma and allied conditions. J Clin Invest 42:1858–1868
Barth WF, Wochner RD, Waldmann TA, Fahey JL (1964) Metabolism of human gamma macroglobulins. J Clin Invest 43:1036–1048
Bhoopalam N, Yakulis V, Costea N, Heller P (1972) Surface immunoglobulins of circulating lymphocytes in mouse plasmacytoma. II. The influence of plasmacytoma RNA on surface immunoglobulins of lymphocytes. Blood 39:465–471
Broder S, Humphrey R, Durm M, Blackman M, Meade B, Goldman C, Strober W, Waldmann T (1975) Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma. N Engl J Med 293:887–892
Brooks WH, Netsky MG, Normansell DE, Horwitz DA (1972) Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136:1631–1647
Caggiano V, Cuttner J, Solomon A (1967) Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma. Blood 30:265–287
Chen Y, Bhoopalam N, Yakulis V, Heller P (1975) Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor. Ann Int Med 83:625–631
Cone L, Uhr JW (1964) Immunological deficiency disorders associated with chronic lymphocytic leukemia and multiple myeloma. J Clin Invest 43:2241–2248
Cwynarski MT, Cohen S (1971) Polyclonal immunoglobulin deficiency in myelomatosis and macroglobulinaemia. Clin Exp Immunol 8:237–248
Douglas SD, Kamin RM, Fudenberg HH (1969) Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol 103:1185–1195
Fahey JL, Humphrey JH (1962) Effect of transplantable plasma-cell tumors on antibody response in mice. Immunology 5:110–115
Fahey JL, Scoggins R, Utz JF, Szwed F (1963) Infection, antibody response and γ-globulin components in multiple myeloma and macroglobulinaemia. Am J Med 35:698–707
Fanger MW, Pelley RP, Reese AL (1972) In vitro demonstration of two antigenically-distinct rabbit lymphocyte populations. J Immunol 109:294–303
Friedman H, Ceglowski WS (1968) Cellular basis for the immunosuppressive properties of a leukaemogenic virus. Nature (Lond) 218:1232–1234
Furth R van, Schuit HRE, Hijmans W (1966) The formation in vitro of paraproteins in multiple myeloma and Waldenström's macroglobulinaemia. Br J Haematol 12:202–211
Gatti RA, Garrioch DB, Good RA (1970) Depressed PHA responses in patients with non-lymphoid malignancies. In: Harris JE (ed) Proceedings fifth leukocyte culture conference. Academic Press, New York, pp 339–358
Giacomoni D, Yakulis V, Wang SR, Cooke A, Dray S, Heller P (1974) In vitro conversion of normal mouse lymphocytes by plasmacytoma RNA to express idiotypic specificities on their surface characteristic of the plasmacytoma immunoglobulin. Cell Immunol 11:389–400
Good RA, Kelly WD, Rotstein J, Vargo RL (1962) Immunological deficiency diseases. Agammaglobulinemia, hypogammaglobulinemia, Hodgkin's disease and sarcoidosis. Progr Allergy 6:187–319
Gronowicz E, Coutinho A, Melchers F (1976) A plaque assay for all cells secreting Ig of a given type of class. Eur J Immunol 6:588–590
Hobbs JR (1969) Immunochemical classes of myelomatosis. Br J Haematol 16:599–606
Janossy G, Greaves MF (1971) Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol 9:483–498
Kennard J, Zolla-Pazner S (1980) Origin and function of suppressor macrophages in myeloma. J Immunol 124:268–273
Kirchner H, Heberman RB, Glaser M, Larvin DH (1974) Suppression of in vitro lymphocyte stimulation in mice bearing primary Molonea sarcoma-induced tumors. Cell Immunol 13:32–40
Mabry RJ, Shelburne J, Cohen HJ (1977) In vitro kinetics of immunoglobulin synthesis by nonsecretory human myeloma cells. Blood 50:1031–1038
MacKenzie MR, Paglieroni T (1976) Studies on the pathogenesis of the immune defect in multiple myeloma. Clin Res 24:148A
MacKenzie MR, Paglieroni T (1977) Multiple myeloma: An immunologic profile. I. Peripheral blood studies. J Immunol 118:1864–1871
McKelvey EM, Fahey JL (1965) Immunoglobulin changes in disease: Quantitation on the basis of heavy polypeptide chains, IgG (G), IgA (A), and IgM (M), and of light polypeptide chains, Type K (I) and Type L (II). J Clin Invest 44:1778–1787
Mellstedt H, Hammarström E, Holm G (1974) Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol 17:371–384
Ossermann EF (1978) Multiple myeloma and related plasma cell dyscrasias. In: Samter M (ed) Immunological diseases. Little, Brown & Co, Boston, pp 499–529
Miller DG, Karnofsky DA (1961) Immunologic factors and resistance to infection in chronic lymphatic leukemia. Am J Med 31:748–757
Munoz J, Pryjma J, Fudenberg HH, Virella G (1980) Immunoglobulin quantitation and enumeration of immunoglobulin-producing cells: Comparison of two indexes of B-cell activation. Scand J Immunol 12:345–353
Preud'Homme JL, Hurez D, Danon F, Brouet JC, Seligmann M (1976) Intracytoplasmic and surface bound immunoglobulins in ‘nonsecretory’ and Bence-Jones myeloma. Clin Exp Immunol 25:428–436
Rühl H, Enders B, Bur M, Sieber G (1981) Impaired B-lymphocyte reactivity in patients with Hodgkin's disease and non-Hodgkin-lymphomas. Blut 42:271–281
Rühl H, Kirchner H (1978) Monocyte-dependent stimulation of human T cells by zinc. Clin Exp Immunol 32:484–488
Rühl H, Rühl U, Sieber G (1980) Immune alterations in patients with Hodgkin's disease. Cell Mol Biol 25:409–414
Rühl H, Scholle H, Bochert G, Vogt W (1978) Activation of lymphocyte subpopulations in patients with chronic lymphocytic leukemia. Zeitschr Immunol Forsch 154:75–87
Salmon SE (1973) Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Seminars Hematol 10:135–147
Scharff MD, Uhr JW (1965) Immunologic deficiency disorders associated with lymphoproliferative diseases. Seminars Hematol 2:47–67
Sieber G, Bochert G, Enders B, Rühl H (1980) Characteristics of immunoglobulin secretion in man evaluated by a reverse hemolytic plaque assay. Blut 41:81–92
Siegel BV, Morton JI (1966) Depressed antibody response in the mouse infected with Rauscher leukaemia virus. Immunology 10:559–562
Smith E, Carlson PJ, Koenig S (1969) Plaque-forming spleen cells following irradiation of X5563 tumor. Proc Soc Exp Biol Med 130:530–534
Smith F, Grenan MM, Owens J (1960) Effect of a transplanted plasma-cell tumor on antibody formation. J Natl Cancer Inst 25:803–812
Solomon A, Waldmann TA, Fahey JL (1963) Clinical and experimental metabolism of normal 6.6S γ-globulin in normal subjects and in patients with macroglobulinemia and multiple myeloma. J Lab Clin Med 62:1–17
Solowey AC, Rapaport FT (1965) Immunologic responses in cancer patients. Surg Gynecol Obstet 121:756–760
Tanapatchaiyapong P, Zolla S (1974) Humoral immunosuppressive substance in mice bearing plasmacytoma. Science 186:748–750
Waldmann TA, Strober W (1969) Metabolism of immunoglobulins. Progr Allergy 13:1–110
Yakulis V, Bhoopalam N, Schade S, Heller P (1972) Surface immunoglobulins of circulating lymphocytes in mouse plasmacytoma. I. Characteristics of lymphocyte surface immunoglobulins. Blood 39:453–464
Zolla S (1972) The effect of plasmacytomas on the immune response of mice. J Immunol 108:1039–1048
Zolla-Pazner S, Sullivan B, Richardson D (1976) Cellular specificity of plasmacytoma-induced immunosuppression. J Immunol 117:563–568
Zolla S, Naor D, Tanapatchaiyapong P (1974) Cellular basis of immunodepression in mice with plasmacytomas. J Immunol 112:2068–2076
Author information
Authors and Affiliations
Additional information
Supported by the Deutsche Forschungsgeminschaft (Ru 21 5/2)
Rights and permissions
About this article
Cite this article
Sieber, G., Enders, B. & Rühl, H. PWM-induced generation of immunoglobulin-secreting cells in patients with multiple myeloma. Klin Wochenschr 59, 1101–1108 (1981). https://doi.org/10.1007/BF01746197
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01746197